title: Minimally Invasive Esophagectomy: A New Era of Surgical Resection.
abstract: Adenocarcinoma of the esophagus continues to increase in incidence and has become a significant health problem in Western countries. While mortality rates are slowly improving from this disease, multimodality treatment, including esophagectomy, has remained critical for optimal outcomes. Esophagectomy has been described as an operation with significant morbidity and mortality, but over the last decade, increased utilization of minimally invasive esophagectomy in an effort to reduce the high rates of morbidity and lengthy hospital stays associated with open esophagectomy has been adopted at many medical centers. We review esophageal cancer treatment modalities, considerations in the current context of neoadjuvant therapy, and increased adoption of minimally invasive approaches.
authors.affiliation: Department of Surgery, Comprehensive Cancer Center, Mount Sinai Medical Center , Miami Beach, Florida.
authors.forename: Daniela
authors.initials: D
authors.lastname: Treitl
authors.affiliation: Department of Surgery, Comprehensive Cancer Center, Mount Sinai Medical Center , Miami Beach, Florida.
authors.forename: Michael
authors.initials: M
authors.lastname: Hurtado
authors.affiliation: Department of Surgery, Comprehensive Cancer Center, Mount Sinai Medical Center , Miami Beach, Florida.
authors.forename: Kfir
authors.initials: K
authors.lastname: Ben-David
mesh_terms: D000230:Adenocarcinoma / Q000601:surgery / Q000628:therapy*; D002294:Carcinoma, Squamous Cell / Q000601:surgery / Q000628:therapy*; D059186:Chemoradiotherapy, Adjuvant; D004938:Esophageal Neoplasms / Q000601:surgery / Q000628:therapy*; D016629:Esophagectomy / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D007902:Length of Stay; D019060:Minimally Invasive Surgical Procedures / Q000009:adverse effects; D020360:Neoadjuvant Therapy